Relapsing fever cost-effectiveness of therapy: Difference between revisions

	Relapsing fever Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Relapsing fever from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Relapsing fever cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Relapsing fever cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Relapsing fever cost-effectiveness of therapy
CDC on Relapsing fever cost-effectiveness of therapy
Relapsing fever cost-effectiveness of therapy in the news
Blogs on Relapsing fever cost-effectiveness of therapy
Directions to Hospitals Treating Relapsing fever
Risk calculators and risk factors for Relapsing fever cost-effectiveness of therapy

Latest revision as of 05:24, 25 September 2020

@@ Line 4: / Line 4: @@
 ===Cost-effective of therapy===
-Although effective antibiotics are on the market, the disease remains a threat to people living in endemic areas.
 ==References==